loadpatents
name:-0.012433052062988
name:-0.0054690837860107
name:-0.0024650096893311
COOKE; Keegan Patent Filings

COOKE; Keegan

Patent Applications and Registrations

Patent applications and USPTO patent grants for COOKE; Keegan.The latest application filed is for "use of oncolytic viruses for the treatment of cancer".

Company Profile
1.5.11
  • COOKE; Keegan - Ventura CA
  • Cooke; Keegan - Menlo Park CA
  • Cooke, Keegan - Palo Alto CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Use Of Oncolytic Viruses For The Treatment Of Cancer
App 20220090133 - DEVOSS; Jason James ;   et al.
2022-03-24
Use Of Oncolytic Viruses, Alone Or In Combination With A Checkpoint Inhibitor, For The Treatment Of Cancer
App 20200009204 - BELTRAN; Pedro J. ;   et al.
2020-01-09
Substrate-powered Energy Storage And Generation System
App 20160351936 - Cooke; Keegan ;   et al.
2016-12-01
Anti-hepcidin antibodies and methods of use
Grant 9,315,577 - Foltz , et al. April 19, 2
2016-04-19
Hepcidin, Hepcidin Antagonists And Methods Of Use
App 20140286953 - Sasu; Barbra ;   et al.
2014-09-25
Hepcidin, hepcidin antagonists and methods of use
Grant 8,629,250 - Sasu , et al. January 14, 2
2014-01-14
Il-22-fc And Hepcidin Activity
App 20130121959 - Maxwell; Joseph R. ;   et al.
2013-05-16
Anti-hepcidin Antibodies And Methods Of Use
App 20110150888 - Foltz; Ian ;   et al.
2011-06-23
Hepcidin, Hepcidin Antagonists And Methods Of Use
App 20080213277 - Sasu; Barbra ;   et al.
2008-09-04
Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
App 20030199093 - Finer, Mitchell H. ;   et al.
2003-10-23
Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
App 20020106799 - Finer, Mitchell H. ;   et al.
2002-08-08
Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
Grant 6,218,187 - Finer , et al. April 17, 2
2001-04-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed